What does that have to do with taxpayer funded R&D for medicine?
Presumably, taneq's point was that medicine owned by taxpayers can be sold at the cost to manufacture and distribute it at far lower costs, as opposed to the current system where the owners of the research also needed to be compensated.
Most (if not all) new medicines came out of basic research supported by the NIH. This research was tweaked and patented by companies who profit from selling the drugs. Is start-to-finish government drug pipeline a better solution? Perhaps, but current academic culture doesn't support it. It's not just about pouring more taxpayer money.
That is awful and I'm so sorry to hear. :( It also doesn't invalidate my point, although it highlights that I should have said the government should run its own competent R&D
You are right, according to medical journal "The Lancet", 85% of (government-funded) research funding is “avoidably wasted across the entire biomedical research range (e.g., clinical, health services, and basic science)” Government-funded medical R&D (budget for the NIH: $34.4 billion for 2019) needs smarter spending.
Presumably, taneq's point was that medicine owned by taxpayers can be sold at the cost to manufacture and distribute it at far lower costs, as opposed to the current system where the owners of the research also needed to be compensated.